Association of diabetes mellitus with myocardial collagen accumulation and relaxation impairment in patients with dilated cardiomyopathy

Diabetes Research and Clinical Practice

Volumn 92, Issue 3, 2011, Pages 348-355

  Sakakibara, Masaki ^a   Hirashiki, Akihiro ^a   Cheng, Xian Wu ^a   Bando, Yasuko ^a   Ohshima, Kei ^a   Okumura, Takahiro ^a   Funahashi, Hidehito ^a   Ohshima, Satoru ^a   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes mellitus; Diastolic dysfunction; Dilated cardiomyopathy; Prognosis

Indexed keywords

COLLAGEN; GLUCOSE; INSULIN;

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE PRESSURE; HEART VENTRICULOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; PROGNOSIS;

ADULT; CARDIOMYOPATHY, DILATED; COLLAGEN; DIABETES MELLITUS; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM;

EID: 79958017626     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.02.023     Document Type: Article

References (23)

1. Garcia M.J., McNamara P.M., Gordon T., Kannel W.B. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 1974, 23:105-111.
2. Murarka S., Movahed M.R. Diabetic cardiomyopathy. J Card Fail 2010, 16:971-979.
3. Rubler S., Dlugash J., Yuceoglu Y.Z., Kumral T., Branwood A.W., Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972, 30:595-602.
4. Fang Z.Y., Prins J.B., Marwick T.H. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004, 25:543-567.
5. Codinach Huix P., Freixa Pamias R. Diabetic cardiomyopathy: concept, heart function, and pathogenesis. Ann Med Int 2002, 19:313-320.
6. Rodrigues B., McNeill J.H. The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res 1992, 26:913-922.
7. Izawa H., Murohara T., Nagata K., Isobe S., Asano H., Amano T., et al. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study. Circulation 2005, 112:2940-2945.
8. Holper E.M., Brooks M.M., Kim L.J., Detre K.M., Faxon D.P. Effects of heart failure and diabetes mellitus on long-term mortality after coronary revascularization (from the BARI Trial). Am J Cardiol 2007, 100:196-202.
9. Pocock S.J., Wang D., Pfeffer M.A., Yusuf S., McMurray J.J., Swedberg K.B., Ostergren J., Michelson E.L., Pieper K.S., Granger C.B. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006, 27:65-75.
10. Guha A., Harmancey R., Taegtmeyer H. Nonischemic heart failure in diabetes mellitus. Curr Opin Cardiol 2008, 23:241-248.
11. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980; 44:672-3.
12. Genuth S., Alberti K.G., Bennett P., Buse J., Defronzo R., Kahn R., et al. Follow-up report on the diagnosis of diabetes mellitus. Diab Care 2003, 26:3160-3167.
13. Mirsky I. Assessment of diastolic function: suggested methods and future considerations. Circulation 1984, 69:836-841.
14. Bertoni A.G., Hundley W.G., Massing M.W., Bonds D.E., Burke G.L., Goff D.C. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diab Care 2004, 27:699-703.
15. Diamant M., Lamb H.J., Groeneveld Y., Endert E.L., Smit J.W., Bax J.J., Romijn J.A., de Roos A., Radder J.K. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 2003, 42:328-335.
16. van Heerebeek L., Hamdani N., Handoko M.L., Falcao-Pires I., Musters R.J., Kupreishvili K., et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 2008, 117:43-51.
17. Kasner M., Westermann D., Steendijk P., Gaub R., Wilkenshoff U., Weitmann K., et al. Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation 2007, 116:637-647.
18. Mullens W., Borowski A.G., Curtin R.J., Thomas J.D., Tang W.H. Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure. Circulation 2009, 119:62-70.
19. Paulus W.J., Vantrimpont P.J., Rousseau M.F. Diastolic function of the nonfilling human left ventricle. J Am Coll Cardiol 1992, 20:1524-1532.
20. Regan T.J., Wu C.F., Yeh C.K., Oldewurtel H.A., Haider B. Myocardial composition and function in diabetes. The effects of chronic insulin use. Circ Res 1981, 49:1268-1277.
21. Boudina S., Abel E.D. Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes. Physiology (Bethesda) 2006, 21:250-258.
22. Taegtmeyer H., McNulty P., Young M.E. Adaptation and maladaptation of the heart in diabetes. Part I. General concepts. Circulation 2002, 105:1727-1733.
23. Szczepaniak L.S., Dobbins R.L., Metzger G.J., Sartoni-D'Ambrosia G., Arbique D., Vongpatanasin W., et al. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 2003, 49:417-423.